We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cambrex Corp | NYSE:CBM | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 59.99 | 0 | 01:00:00 |
The Company will host a conference call to discuss the financial results.
Third Quarter 2016 Earnings Conference Call | ||
When: | Friday, November 4, 2016 at 8:30 a.m. Eastern Time | |
Dial-in: | 1-888-262-8770 for U.S. | |
1-913-312-1227 for International | ||
Passcode: 2914880 | ||
Dial-in Replay: | 1-888-203-1112 for U.S. | |
1-719-457-0820 for International | ||
Passcode: 2914880 | ||
Available through Friday, November 11, 2016 | ||
Webcast: | www.cambrex.com | |
About CambrexCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. For more information, please visit www.cambrex.com.
Contact: Stephanie LaFiura Investor Relations Associate Tel: 201-804-3037 Email: stephanie.lafiura@cambrex.com
1 Year Cambrex Chart |
1 Month Cambrex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions